The pharmaceutical landscape for blood sugar is evolving, and transdermal GLP-1 delivery systems represent a exciting advance. Unlike subcutaneous injections, this approach offers a less invasive way to deliver GLP-1 https://ronaldmbif403540.loginblogin.com/49120487/glp-1-patches-a-new-approach-to-diabetes-management